TherapeuticsMD (TXMD) Common Equity (2010 - 2026)
TherapeuticsMD's Common Equity was $27.13 million in Q2 2026, down 0.6% from $27.29 million a year earlier but up 0.6% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at TherapeuticsMD came in at $26.88 million, down 1.8% from FY2024.
- Common Equity has now declined for three consecutive years.
- In earlier years, Common Equity was $27.37 million in FY2024 (-6.5%), $29.29 million in FY2023 (-16.7%), $35.14 million in FY2022 and -$93.62 million in FY2021.
- Quarterly Common Equity has moved between -$140.58 million (Q1 2022) and $35.14 million (Q4 2022) over five years.
- Compared with a year earlier, Common Equity was higher in two of the last eight quarters, with an average decline of 2.3%.
- The best year-over-year quarter for Common Equity over five years was Q3 2025 (growth of 1.3%); the worst was Q4 2023 (a decline of 16.7%).
- Per Business Quant data, TXMD's Common Equity in the three quarters before Q2 2026 was $26.97 million (Q1 2026), $26.88 million (Q4 2025) and $27.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 27.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.13 Mn |
| Mar 31, 2026 | 26.97 Mn |
| Dec 31, 2025 | 26.88 Mn |
| Sep 30, 2025 | 27.44 Mn |
| Jun 30, 2025 | 27.29 Mn |
| Mar 31, 2025 | 26.74 Mn |
| Dec 31, 2024 | 27.37 Mn |
| Sep 30, 2024 | 27.09 Mn |
| Jun 30, 2024 | 27.67 Mn |
| Mar 31, 2024 | 28.66 Mn |
| Dec 31, 2023 | 29.29 Mn |
| Sep 30, 2023 | 28.05 Mn |
| Jun 30, 2023 | 31.20 Mn |
| Mar 31, 2023 | 32.02 Mn |
| Dec 31, 2022 | 35.14 Mn |
| Sep 30, 2022 | -48.27 Mn |
| Jun 30, 2022 | -26.07 Mn |
| Mar 31, 2022 | -140.58 Mn |
| Dec 31, 2021 | -93.62 Mn |
| Sep 30, 2021 | -57.36 Mn |
API Access
TherapeuticsMD Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();